|
1
|
Bauer HM and Ault K: Human papillomavirus:
Current prevalence and future Protection. Sex Trans Dis.
33:509–511. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chih HJ, Lee AH, Colville L, Binns CW and
Xu D: A review of dietary prevention of human
papillomavirus-related infection of the cervix and
cervicalintraepithelial neoplasia. Nutr Cancer. 65:317–328. 2013.
View Article : Google Scholar
|
|
3
|
Qian JH, Xie X and Yie DF: Epidemiologic
features of human paplillomavirus infection in cervix. Chin J
Obstet Gynecol. 38:712–714. 2006.
|
|
4
|
Martin CM and O’Leary JJ: Histology of
cervical intraepithelial neoplasia and the role of biomarkers. Best
Pract Res Clin Obstet Gynaecol. 25:605–615. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dascau V, Furau G, Furau C, Paiusan L, et
al: Cervical intraepithelial neoplasia in the ‘dr. Salvator vuia’
clinical obstetrics and gynecology hospital - arad during the
2000–2009 period. Maedica (Buchar). 7:138–142. 2012.
|
|
6
|
Walts AE, Lechago LJ and Bose S: P16 and
Ki67 immunostaining is a useful adjunct in the assessment of
biopsies for HPV-associated anal intraepithelial neoplasia. Am J
Surg Pathol. 30:795–801. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Monsonego J, Pintos J, Semaille C, Beumont
M, et al: Human papillomavirus testing improves the accuracy of
colposcopy in detection of cervical intraepithelial neoplasia. Int
J Gynecol Cancer. 16:591–598. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Massad LS, Einstein MH, Huh WK and Katki
HA: 2012 updated consensus guidelines for the management of
abnormal cervical cancer screening tests and cancer precursors. J
Low Genit Tract Dis. 17(5 Suppl 1): S1–S27. 2013. View Article : Google Scholar
|
|
9
|
Tsoumpou I, Arbyn M, Kyrgiou M, Wentzensen
N, et al: p16(INK4a) immunostaining in cytological and histological
specimens from the uterine cervix: a systematic review and
meta-analysis. Cancer Treat Rev. 35:210–220. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sano T, Oyama T, Kashiwabara K, Fukuda T
and Nakajima T: Expression status of p16 protein is associated with
human papillomavirus oncogenic potential in cervical and genital
lesions. Am J Pathol. 153:1741–1748. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sotlar K, Diemer D, Dethleffs A, Hack Y,
et al: Detection and typing of human papillomavirus by E6 nested
multiplex PCR. J Clin Microbiol. 42:3176–3184. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gheit T and Tommasino M: Detection of
high-risk mucosal human papillomavirus DNA in human specimens by a
novel and sensitive multiplex PCR method combined with DNA
microarray. Methods Mol Biol. 665:195–212. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shirendeb U, Hishikawa Y, Moriyama S, Win
N, et al: Human papillomavirus infection and its possible
correlation with p63 expression in cervical cancer in Japan,
Mongolia, and Myanmar. Acta Histochem Cytochem. 42:181–190. 2009.
View Article : Google Scholar
|
|
14
|
Lax S: Histopathology of cervical
precursor lesions and cancer. Acta Dermatovenerol Alp Panonica
Adriat. 20:125–133. 2011.PubMed/NCBI
|
|
15
|
Sakaguchi M, Fujii Y, Hirabayashi H, Yoon
HE, et al: Inversely correlated expression of p16 and Rb protein in
non-small cell lung cancers: an immunohistochemical study. Int J
Cancer. 65:442–445. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sano T, Oyama T, Kashiwabara K, Fukuda T
and Nakajima T: Immunohistochemical overexpression of p16 protein
associated with intact retinoblastoma protein expression in
cervical cancer and cervical intraepithelial neoplasia. Pathol Int.
48:580–585. 1998. View Article : Google Scholar
|
|
17
|
Koshiol J, Lindsay L, Pimenta JM, Poole C,
et al: Persistent human papillomavirus infection and cervical
neoplasia: a systematic review and meta-analysis. Am J Epidemiol.
168:123–137. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Carozzi F, Gillio-Tos A, Confortini M, et
al: Risk of high-grade cervical intraepithelial neoplasia during
follow-up in HPV-positive women according to baseline p16-INK4A
results: a prospective analysis of a nested substudy of the NTCC
randomised controlled trial. Lancet Oncol. 14:168–176. 2013.
View Article : Google Scholar
|
|
19
|
Lesnikova I, Lidang M, Hamilton-Dutoit S
and Koch J: p16 as a diagnostic marker of cervical neoplasia: a
tissue microarray study of 796 archival specimens. Diagn Pathol.
4:222009. View Article : Google Scholar
|
|
20
|
Lee S, Kim H, Kim H, Kim C and Kim I: The
utility of p16INK4a and Ki-67 as a conjunctive tool in uterine
cervical lesions. Korean J Pathol. 46:253–260. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin ZH, Liu MZ, Zhao YW, Wu QY, et al:
Study of p16 expression and DNA ploidy in HPV-negative cervical
cancers and precursors. Chin J Pathol. 35:412–416. 2006.(In
Chinese).
|
|
22
|
Soma M and Kamaraj S: Detection of human
papillomavirus in cervical gradings by immunohistochemistry and
typing of HPV 16 and 18 in high-grades by polymerase chain
reaction. J Lab Physicians. 2:31–36. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Samir R, Asplund A, Tot T, Pekar G and
Hellberg D: High-risk HPV infection and CIN grade correlates to the
expression of c-myc, CD4+, FHIT, E-cadherin, Ki-67, and p16INK4a. J
Low Genit Tract Dis. 15:280–286. 2011.PubMed/NCBI
|
|
24
|
Yim EK and Park JS: Biomarkers in cervical
cancer. Biomark Insights. 7:215–225. 2007.
|
|
25
|
Kuo KT, Chang HC, Hsiao CH and Lin MC:
Increased Ki-67 proliferative index and absence of P16INK4 in
CIN-HPV related pathogenic pathways different from cervical
squamous intraepithelial lesion. Br J Ophthalmol. 90:894–899. 2006.
View Article : Google Scholar
|
|
26
|
Kong CS, Balzer BL, Troxell ML, Patterson
BK and Longacre TA: p16INK4A immunohistochemistry is superior to
HPV in situ hybridization for the detection of high-risk HPV in
atypical squamous metaplasia. Am J Surg Pathol. 31:33–43. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bragança JF, Sarian LO, Pitta DR, Maito
AB, et al: Expression of p16(INK4a) and cervical infection with
high-risk human papillomavirus are not related to p53 activity in
cervical intraepithelial neoplasia. Int J Gynecol Cancer.
18:1060–1064. 2008.PubMed/NCBI
|
|
28
|
Türkçüoğlu I, Tezcan S, Kaygusuz G,
Atabekoğlu CS, et al: The role of p53, Bcl-2 and Ki-67 in
premalignant cervical lesions and cervical cancer. Eur J Gynaecol
Oncol. 28:290–293. 2007.PubMed/NCBI
|
|
29
|
Giannoudis and Herrington CS: Differential
expression of p53 and p21 in low grade cervical squamous
intraepithelial lesions infected with low, intermediate, and high
risk human papillomaviruses. Cancer. 89:1300–1307. 2000. View Article : Google Scholar
|
